Filing Details
- Accession Number:
- 0001209191-21-035523
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-05-24 19:27:50
- Reporting Period:
- 2021-05-20
- Accepted Time:
- 2021-05-24 19:27:50
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1796280 | Oric Pharmaceuticals Inc. | ORIC | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1608936 | Jacob Chacko | C/O Oric Pharmaceuticals, Inc. 240 E. Grand Ave., 2Nd Floor South San Francisco CA 94080 | President And Ceo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2021-05-20 | 2,468 | $25.07 | 27,934 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2021-05-21 | 4,790 | $25.20 | 23,144 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2021-05-24 | 12 | $25.00 | 23,132 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Footnotes
- The sales reported were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
- Represents the weighted average share price of an aggregate total of 2,468 shares sold in the price range of $25.00 to $25.14 by the Reporting Person. The Reporting Person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
- Represents the weighted average share price of an aggregate total of 4,790 shares sold in the price range of $25.00 to $25.37 by the Reporting Person. The Reporting Person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
Billionaire Hedge Funds
